BioJapan takes place in Yokohama, Japan on October 7-9, 2026. The meeting is held in parallel with Regenerative Medicine Japan and healthTECH Japan and is Asia’s largest partnering event, providing the opportunity for pharmaceutical companies and biotechs to connect with representatives from academia and CROs.
With long experience in supporting pharma clients in drug discovery, with a particular focus on target and lead discovery in neurobiology, Cellectricon is looking forward to taking part in the meeting. If you are interested in learning more about Cellectricon’s neuroscience drug discovery services, reach out to setup a meeting with Mattias Karlsson, our CEO, or Stefan Sandström, our Head of Japan Business Development.
Mattias Karlsson, CEO
Meet us at BioJapan 2026!
We are looking forward to taking part in this year’s meeting and for the opportunity to strengthening our long-term engagement with Japanese pharmaceutical and biotech partners. Get in touch if you are interested in setting up a meeting to learn more about Cellectricon’s neuroscience-focused drug discovery services and platforms.